These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 19756586)
1. Inhibition of Candida albicans growth by brominated furanones. Duo M; Zhang M; Luk YY; Ren D Appl Microbiol Biotechnol; 2010 Feb; 85(5):1551-63. PubMed ID: 19756586 [TBL] [Abstract][Full Text] [Related]
2. RTA2, a novel gene involved in azole resistance in Candida albicans. Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis. Zeng YB; Qian YS; Ma L; Gu HN Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans. Lee RE; Liu TT; Barker KS; Lee RE; Rogers PD J Antimicrob Chemother; 2005 May; 55(5):655-62. PubMed ID: 15814599 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Liu TT; Lee RE; Barker KS; Lee RE; Wei L; Homayouni R; Rogers PD Antimicrob Agents Chemother; 2005 Jun; 49(6):2226-36. PubMed ID: 15917516 [TBL] [Abstract][Full Text] [Related]
6. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance. Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273 [TBL] [Abstract][Full Text] [Related]
8. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671 [TBL] [Abstract][Full Text] [Related]
9. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687 [TBL] [Abstract][Full Text] [Related]
10. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans. Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793 [TBL] [Abstract][Full Text] [Related]
11. Human fungal pathogen Candida albicans in the postgenomic era: an overview. Kabir MA; Hussain MA Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061 [TBL] [Abstract][Full Text] [Related]
12. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes. Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368 [TBL] [Abstract][Full Text] [Related]
14. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole. Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475 [TBL] [Abstract][Full Text] [Related]
15. Serum repressing efflux pump CDR1 in Candida albicans. Yang YL; Lin YH; Tsao MY; Chen CG; Shih HI; Fan JC; Wang JS; Lo HJ BMC Mol Biol; 2006 Jul; 7():22. PubMed ID: 16839415 [TBL] [Abstract][Full Text] [Related]
16. Substrates and modulators of the multidrug transporter Cdr1p of Candida albicans in antifungal extracts of medicinal plants. Kolaczkowski M; Kolaczkowska A; Sroda K; Ramalhete C; Michalak K; Mulhovo S; Ferreira MJ Mycoses; 2010 Jul; 53(4):305-10. PubMed ID: 19460101 [TBL] [Abstract][Full Text] [Related]
17. 2-amino-nonyl-6-methoxyl-tetralin muriate activity against Candida albicans augments endogenous reactive oxygen species production --a microarray analysis study. Liang RM; Yong XL; Jiang YP; Tan YH; Dai BD; Wang SH; Hu TT; Chen X; Li N; Dong ZH; Huang XC; Chen J; Cao YB; Jiang YY FEBS J; 2011 Apr; 278(7):1075-85. PubMed ID: 21251230 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia. Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495 [TBL] [Abstract][Full Text] [Related]
19. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients. Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060 [TBL] [Abstract][Full Text] [Related]
20. Identifying the important structural elements of brominated furanones for inhibiting biofilm formation by Escherichia coli. Han Y; Hou S; Simon KA; Ren D; Luk YY Bioorg Med Chem Lett; 2008 Feb; 18(3):1006-10. PubMed ID: 18164977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]